TELOMERE SHORTENING
Clinical trials for TELOMERE SHORTENING explained in plain language.
Never miss a new study
Get alerted when new TELOMERE SHORTENING trials appear
Sign up with your email to follow new studies for TELOMERE SHORTENING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gene therapy aims to fix bone marrow in rare telomere disease
Disease control OngoingThis early-phase study tests a new treatment called EXG34217 in 12 people aged 12 and older who have bone marrow failure due to telomere biology disorders. The main goal is to see if the treatment is safe and tolerable. Researchers will also check if it improves blood cell counts…
Matched conditions: TELOMERE SHORTENING
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Diet and exercise may slow aging at the cellular level
Knowledge-focused OngoingThis study looks at how nutritional counseling and physical exercise affect cell aging in elderly women. Researchers will measure telomere length (a marker of cell age) and other aging-related markers in 60 women aged 60-75, some with obesity and some without. The goal is to unde…
Matched conditions: TELOMERE SHORTENING
Phase: NA • Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC